1. Home
  2. LITE vs INSM Comparison

LITE vs INSM Comparison

Compare LITE & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lumentum Holdings Inc.

LITE

Lumentum Holdings Inc.

HOLD

Current Price

$926.18

Market Cap

24.1B

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$104.60

Market Cap

23.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITE
INSM
Founded
2015
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.1B
23.0B
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
LITE
INSM
Price
$926.18
$104.60
Analyst Decision
Buy
Strong Buy
Analyst Count
15
24
Target Price
$645.43
$201.17
AVG Volume (30 Days)
5.3M
4.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
104.56
N/A
EPS
2.59
N/A
Revenue
$1,247,700,000.00
N/A
Revenue This Year
$79.88
$182.31
Revenue Next Year
$66.61
$65.19
P/E Ratio
$362.16
N/A
Revenue Growth
24.57
N/A
52 Week Low
$80.39
$70.57
52 Week High
$1,085.68
$212.75

Technical Indicators

Market Signals
Indicator
LITE
INSM
Relative Strength Index (RSI) 51.24 35.54
Support Level $820.17 $98.90
Resistance Level $942.75 $166.81
Average True Range (ATR) 80.01 3.90
MACD -3.12 0.82
Stochastic Oscillator 50.52 30.97

Price Performance

Historical Comparison
LITE
INSM

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: